MétaCan
Menu
Back to cohort
Record W4407863613 · doi:10.1158/2326-6074.io2025-a015

Abstract A015: GPNMB CAR T cells target both Glioblastoma and its immunosuppressive niche to relieve immune evasion

2025· article· en· W4407863613 on OpenAlexaff
Sheila K. Singh, Neil Savage, Franz J. Zemp, Vaseem Shaikh, Shan Grewal, Nicholas Mikolajewicz, Hinda Najem, Chitra Venugopal, Thomas Kislinger, Amy B. Heimberger, Douglas J. Mahoney, Jason Moffat

Bibliographic record

VenueCancer Immunology Research · 2025
Typearticle
Languageen
FieldMedicine
TopicCAR-T cell therapy research
Canadian institutionsUniversity of CalgaryUniversity of TorontoMcMaster University
Fundersnot available
KeywordsEvasion (ethics)GlioblastomaNicheImmune systemImmunotherapyImmunologyCancer immunotherapyBiologyCancer researchMedicineEcology

Abstract

fetched live from OpenAlex

Abstract Glioblastoma (GBM) remains a formidable challenge in neuro-oncology, characterized by heterogeneity and aggressive tumor growth. The identification of novel biomarkers and therapeutic targets is crucial for advancing promising therapies. This study profiled patient-derived tumor samples utilizing single-cell RNA sequencing and proteomics platforms to uncover the upregulation of glycoprotein non-metastatic melanoma protein B (GPNMB) in tumor cells, particularly in post-treatment recurrent tumor cells, as well as in tumor-associated macrophages (TAMs), which constitute a major population of immune cells in treatment-refractory recurrent GBM. By exploring its expression patterns against normal tissue specimens and utilizing a series of patient-derived xenograft and humanized mouse models, we explored GPNMB as a target for Chimeric Antigen Receptor T cells (CAR-Ts) as a monotherapy and in rationally designed combination treatment regimens. We also demonstrated the utility of the GPNMB CAR-T cell in eliminating TAMs, a major contributor to immunosuppression in solid tumors. Our study reveals the development of GPNMB-targeting therapies as part of a promising and effective combinatorial treatment strategy for GBM. Citation Format: Sheila K Singh, Neil Savage, Franz J Zemp, Vaseem Shaikh, Shan Grewal, Nicholas Mikolajewicz, Hinda Najem, Chitra Venugopal, Thomas Kislinger, Amy Heimberger, Douglas Mahoney, Jason Moffat. GPNMB CAR T cells target both Glioblastoma and its immunosuppressive niche to relieve immune evasion [abstract]. In: Proceedings of the AACR IO Conference: Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy; 2025 Feb 23-26; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Immunol Res 2025;13(2 Suppl):Abstract nr A015.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Research integrity, Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.105
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.002
Science and technology studies0.0010.001
Scholarly communication0.0000.000
Open science0.0010.001
Research integrity0.0010.003
Insufficient payload (model declined to judge)0.0050.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.039
GPT teacher head0.392
Teacher spread0.353 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueCancer Immunology ResearchSame topicCAR-T cell therapy researchFrench-language works237,207